TIS 0.00% 0.0¢ tissue therapies limited

chmp meeting minutes, page-10

  1. 2,359 Posts.
    lightbulb Created with Sketch. 345
    The following is from yesterdays announcement , note 1 :

    At 31 December 2013, and based on stability analysis already undertaken which indicates a stable profile for the commercial lifetime of the product, Management has assessed that the inventory of VitroGro® ECM is not impaired and no impairment provision has been raised. Management is therefore confident that the carrying value of finished goods of VitroGro® ECM at 31 December 2013 is recoverable provided the following circumstances can be achieved:
    ? Regulatory resolution to allow sales of product in line with forecast sales, and
    ? The process under the relevant regulatory procedures allows an extension to the shelf life of the March 2012 batch at the time it is
    requested, and;
    ? The additional cost of relabeling the finished goods of VitroGro® ECM is absorbed by the available margin in the sales price.

    ***The Directors are of the view that the above can be achieved and therefore believe that the carrying value of finished goods of VitroGro® ECM is recoverable.***
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.